Journals / Türk Osteoporoz Dergisi / 2020 / Cilt: 26 - Sayı: 2

The Relationship Between Iron Accumulation, Vitamin D Deficiency and Bone Mineral Density in Patients with Thalassemia Major, Thalassemia Intermedia and Sickle Cell

Talasemi Majör, İntermedya ve Orak Hücreli Hastalarda Demir Birikimi ve D Vitamini Eksikliği ile Kemik Mineral Yoğunluğu İlişkisi

Pages
121–126
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When the patients’ ferritin values and DEXA scoreswere compared, femur T-score, lumbar T-score, femur Z-score and lumbar Z-score were significantly lower in those with high ferritin values (pvalues were respectively: 0.0005, 0.0002,

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Osteopenia and osteoporosis are important causes of morbidity in patients with hemoglobinopathies.
📊
Key Findings & Data:This study investigates theassociation between iron accumulation, vitamin D and bone mineral density (BMD) in patients with thalassemia major, thalassemia intermediaand sickle cell.Materials and Methods: Serum samples collected from 102 patients with hemoglobinopathy were used; the relationship between ferritin,vitamin D levels and BMD, which was performed with dual energy X-ray absorptiometry (DEXA), was investigated.Results: The ratio of thalassemia intermedia, thalassemia major and sickle cell patients with normal BMD according to the DEXA FemoralT-score was 56.25%, 35% and 39%, respectively.
💡
Conclusion & Impact:When the patients’ ferritin values and DEXA scoreswere compared, femur T-score, lumbar T-score, femur Z-score and lumbar Z-score were significantly lower in those with high ferritin values (pvalues were respectively: 0.0005, 0.0002,
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Osteopenia and osteoporosis are important causes of morbidity in patients with hemoglobinopathies. This study investigates theassociation between iron accumulation, vitamin D and bone mineral density (BMD) in patients with thalassemia major, thalassemia intermediaand sickle cell.Materials and Methods: Serum samples collected from 102 patients with hemoglobinopathy were used; the relationship between ferritin,vitamin D levels and BMD, which was performed with dual energy X-ray absorptiometry (DEXA), was investigated.Results: The ratio of thalassemia intermedia, thalassemia major and sickle cell patients with normal BMD according to the DEXA FemoralT-score was 56.25%, 35% and 39%, respectively. The ratio of thalassemia intermedia, thalassemia major and sickle cell patients with normalBMD according to the DEXA lumbar T-score was 31.25%, 7.5% and 41.25%, respectively. When the patients’ ferritin values and DEXA scoreswere compared, femur T-score, lumbar T-score, femur Z-score and lumbar Z-score were significantly lower in those with high ferritin values (pvalues were respectively: 0.0005, 0.0002,

Özet

Amaç: Osteopeni ve osteoporoz hemoglobinopatili hastalarda önemli bir morbidite nedenidir. Bu çalışmanın amacı talasemi majör, talasemi intermedya ve orak hücreli anemi hastalarında demir birikimi, D vitamini ve kemik mineral yoğunluğu (KMY) arasındaki ilişkiyi araştırmaktır. Gereç ve Yöntem: Hemoglobinopatili 102 hastadan serum örnekleri toplandı ve ferritin ve D vitamini düzeyleri ile çift enerjili X-ışını absorpsiyometrisiyle (DEXA) ölçülen KMY arasındaki ilişki araştırıldı. Bulgular: DEXA femoral T-skoruna göre normal KMY olan talasemi intermedya, talasemi majör ve orak hücreli anemi hasta oranı sırasıyla %56,25, %35 ve %39 idi. DEXA lomber T-skoruna göre normal KMY olan talasemi intermedya, talasemi majör ve orak hücreli anemi hasta oranı sırasıyla %31,25, %7,5 ve %41,25 idi. Hastaların ferritin değerleri ve DEXA skorları karşılaştırıldığında, femur T-skoru, lomber T-skoru, femur Z-skoru ve lomber Z-skoru, ferritin değeri yüksek olanlarda istatistiksel olarak anlamlı derecede düşüktü (p değerleri sırasıyla: 0,0005, 0,0002,

🔖

Cite This Article

BÜYÜKŞİMŞEK, M., BAŞLAMIŞLI, İ. F. (2022). The Relationship Between Iron Accumulation, Vitamin D Deficiency and Bone Mineral Density in Patients with Thalassemia Major, Thalassemia Intermedia and Sickle Cell. Türk Osteoporoz Dergisi, Cilt: 26 - Sayı: 2, 121–126. https://ajindex.com/articles/639646

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Haidar R, Musallam KM, Taher AT. Bone disease and skeletal complications in patients with β thalassemia major. Bone 2011;48:425-32
  2. Tyler PA, Madani G, Chaudhuri R, Wilson LF, Dick EA. Theradiological appearances of thalassaemia. Clin Radiol 2006;61:40-52
  3. Dundar U, Kupesiz A, Ozdem S, Gilgil E, Tuncer T, Yesilipek A, et al. Bone metabolism and mineral density in patients with betathalassemia major. Saudi Med J 2007;28:1425-9
  4. Gaudio A, Morabito N, Xourafa A, Macrì I, Meo A, Morgante S, et al. Bisphosphonates in the treatment of thalassemia-associated osteoporosis. J Endocrinol Invest 2008;31:181-4
  5. Vogiatzi MG, Autio KA, Schneider R, Giardina PJ. Low bone mass in prepubertal children with thalassemia major: insights in to the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab 2004;17:1415-21
  6. Lorincz C, Manske SL, Zernicke R. Bone health: part 1, nutrition. Sports Health 2009;1:253-60
  7. Balogh E, Paragh G, Jeney V. Influence of Iron on Bone Homeostasis. Pharmaceuticals (Basel) 2018;11
  8. Dede AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, Dontas I, Papaioannou N, et al. Thalassemia-associated osteoporosis: asystematic review on treatmentandbrief overview of the disease. Osteoporos Int 2016;27:3409-25
  9. Hamdy M, Salama N, Maher G, Elrefaee A. Vitamin D and Nonskeletal Complications among Egyptian Sickle Cell Disease Patients. Adv Hematol 2018;2018:3867283
  10. Nakamura K, Ueno K, Nishiwaki T, Okuda Y, Saito T, Tsuchiya Y, et al. Nutrition, mild hyperparathyroidism, and bone mineral density in youngJapanesewomen. Am J Clin Nutr 2005;82:1127-33
  11. Vupputuri MR, Goswami R, Gupta N, Ray D, Tandon N, Kumar N. Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptorgene polymorphisms in Asian Indians. Am J Clin Nutr 2006;83:1411-9
  12. Pirinççioğlu AG, Akpolat V, Köksal O, Haspolat K, Söker M. Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone 2011;49:819-23
  13. Frisk P, Arvidson J, Ljunggren O, Gustafsson J. Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D. Bone Marrow Transplant 2012;47:657-62
  14. Miller RG, Segal JB, Ashar BH, Leung S, Ahmed S, Siddique S, et al. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol 2006;81:236- 41
  15. Bielinski BK, Darbyshire P, Mathers L, Boivin CM, Shaw NJ. Bone density in the Asia